ProMIS Neurosciences is focused on the treatment of Alzheimer’s disease, amyotrophic lateral sclerosis and multiple system atrophy through the discovery and development of antibodies selective for toxic misfolded proteins driving these diseases.
View Top Employees from ProMIS™ Neurosciences, Inc.| Website | http://promisneurosciences.com/ |
| Ticker | PMN |
| Revenue | $750000 |
| Employees | 20 (8 on RocketReach) |
| Founded | 2015 |
| Address | 1920 Yonge St., Suite 200, Toronto, Ontario M4S 3E2, CA |
| Phone | (416) 847-6898 |
| Fax | (416) 847-6899 |
| Technologies |
JavaScript,
HTML,
PHP
+30 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services, Science and Engineering, Precision Medicine, Health Diagnostics, Neurodegenerative Diseases, Health Care, Alzheimer's Disease, Medical, Amyotrophic Lateral Sclerosis (ALS), Neuroscience, Therapeutics |
| Web Rank | 9 Million |
| Keywords | Promis Neurosciences, Neurodegenerative Disease Companies, Promis Neuroscience, Expert Panel Press Release, Promis Canadian Public Comapny |
| Competitors | Genelux, Metacrine, Inc., Neuren Pharmaceuticals, Optherion, Inc., Sirius Genomics |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular ProMIS™ Neurosciences, Inc. employee's phone or email?
ProMIS™ Neurosciences, Inc. Questions
The ProMIS™ Neurosciences, Inc. annual revenue was $750000 in 2024.
Gail Farfel is the CEO of ProMIS™ Neurosciences, Inc..
8 people are employed at ProMIS™ Neurosciences, Inc..
ProMIS™ Neurosciences, Inc. is based in Toronto, Ontario.
The NAICS codes for ProMIS™ Neurosciences, Inc. are [5417, 541714, 54171, 541, 54].
The SIC codes for ProMIS™ Neurosciences, Inc. are [873, 87].
Top ProMIS™ Neurosciences, Inc. Employees
-
53
-
44
-
34
-
55
-
View
Beibei Zhao
Director, Research Programs at ProMIS™ Neurosciences, Inc.
Vancouver, British Columbia, Canada2 -
View
Max Milbury
Director, Finance at ProMIS™ Neurosciences, Inc.
Cambridge, Massachusetts, United States34 -
25+
Related Companies
